Pharmaswiss Ceska republika s.r.o. (an affiliate of Bausch & Lomb UK Limited) is recalling all unexpired batches of Emerade 300 microgram auto-injectors (also referred to as pens) from patients due to an error in one component of the auto-injector believed to cause some pens to fail to activate and deliver adrenaline. More information is provided in the attached alert.
Healthcare professionals (GP Practices, Pharmacies) should, contact patients and carers with Emerade 300mcg pens, to inform them of the recall information contained within this alert. Additional advice has also been provided for patients with Emerade 500mcg pens, which are not currently subject to a recall due to insufficient supplies of alternative brands of pens.
MHRA April 2020 -Emarade 300 MHRA April 2020 -Emarade 500
Patient issued with it had it issued in 2018